CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Research alert: use of metformin associated with exceptional longevity among older women Dr. Kamal Kant Kohli23 May 2025 9:00 AM ISTThere is increasing interest in finding drugs, known as gerotherapeutics, that can slow aging and help people live longer. Metformin, a common...
Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks Dr. Yalamanchi Amulya13 May 2025 9:00 AM ISTPrediabetes is a clinical precursor not only to diabetes but also to emerging cognitive impairment and neuropsychiatric symptoms. In a cohort of...
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac Farhat Nasim9 May 2025 7:51 PM ISTEmpagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Metformin May Ease Knee Pain in Overweight Osteoarthritis Patients: Randomized Trial Suggests Modest Benefit Medha Baranwal28 April 2025 5:30 AM ISTAustralia: A new randomized clinical trial has demonstrated that metformin, a drug commonly used to manage type 2 diabetes, may significantly reduce...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Metformin: A Potential Therapy for Periodontal Tissue Repair following periodontitis Dr. Shravani Dali13 April 2025 9:00 PM ISTResearchers have found in a new research that Metformin shows promise in promoting periodontal tissue repair following periodontitis. It is attained...
Prediabetes and CV Risk: Evidence Review in 2025 Dr.Soumya S L11 April 2025 12:30 PM ISTPrediabetes: Potential Cardiovascular (CV) Warning Sign: India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
